Literature DB >> 7418404

Endometrial estrogen and progestin receptors in women bearing a progesterone-releasing intrauterine device.

O Jänne, P Ylöstalo.   

Abstract

Endometrial biopsies were obtained from eleven volunteers bearing a progesterone-releasing intrauterine device (IUD). The mean treatment time was 4.1 yrs (range 1--5 yrs). Tissue samples were collected during the follicular phase of the cycle and assayed for estrogen and progestin receptors with [3H] estradiol and [3H] ORG 2058 (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) as the respective radioactive ligands. Both receptor values were significantly lower (p < 0.01) than those present in endometrial tissue of normally menstruating women. The steroid receptor concentrations measured (estrogen receptor 19.6 +/- 9.9 and progestin receptor 134.4 +/- 121/4 fmol/mg cytosol protein) from women with an IUD represented only about 20% of those in endometria of normal women. This result suggests that progesterone released from the IUD has a depressive action on the sex steroid receptor levels which may contribute to the contraceptive effectiveness of the IUD.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418404     DOI: 10.1016/0010-7824(80)90113-4

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

1.  Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.

Authors:  Alison J Eastman; Ingrid L Bergin; Daniel Chai; Christine M Bassis; William LeBar; George O Oluoch; Emma R Liechty; Atunga Nyachieo; Vincent B Young; David M Aronoff; Dorothy L Patton; Jason D Bell
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

2.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.

Authors:  Ashley S Felix; Mia M Gaudet; Carlo La Vecchia; Christina M Nagle; Xiao Ou Shu; Elisabete Weiderpass; Hans Olov Adami; Shirley Beresford; Leslie Bernstein; Chu Chen; Linda S Cook; Immaculata De Vivo; Jennifer A Doherty; Christine M Friedenreich; Susan M Gapstur; Dierdre Hill; Pamela L Horn-Ross; James V Lacey; Fabio Levi; Xiaolin Liang; Lingeng Lu; Anthony Magliocco; Susan E McCann; Eva Negri; Sara H Olson; Julie R Palmer; Alpa V Patel; Stacey Petruzella; Jennifer Prescott; Harvey A Risch; Lynn Rosenberg; Mark E Sherman; Amanda B Spurdle; Penelope M Webb; Lauren A Wise; Yong-Bing Xiang; Wanghong Xu; Hannah P Yang; Herbert Yu; Anne Zeleniuch-Jacquotte; Louise A Brinton
Journal:  Int J Cancer       Date:  2014-09-30       Impact factor: 7.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.